State Street Corp Ani Pharmaceuticals Inc Transaction History

State Street Corp

$2.59 Trillion
Q2 2025

A detailed history of State Street Corp transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, State Street Corp holds 716,117 shares of ANIP stock, worth $68.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

716,117

Previous 714,570 0.22%

Holding current value

$68.2 Million

Previous $47.8 Million 2.33%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$57.79 - $72.95 $89,401 - $112,853	1,547 Added 0.22%	716,117 $46.7 Million
Q1 2025 May 15, 2025	SELL	$53.93 - $68.36 $1.23 Million - $1.55 Million	-22,718 Reduced 3.08%	714,570 $47.8 Million
Q4 2024 Feb 14, 2025	BUY	$53.35 - $61.74 $1.78 Million - $2.06 Million	33,445 Added 4.75%	737,288 $40.8 Million
Q3 2024 Nov 14, 2024	BUY	$54.33 - $65.72 $3.19 Million - $3.86 Million	58,698 Added 9.1%	703,843 $42 Million
Q2 2024 Aug 14, 2024	BUY	$58.53 - $68.82 $4.12 Million - $4.84 Million	70,307 Added 12.23%	645,145 $41.1 Million
Q1 2024 May 15, 2024	SELL	$54.2 - $69.69 $953,107 - $1.23 Million	-17,585 Reduced 2.97%	574,838 $39.7 Million
Q4 2023 Feb 14, 2024	BUY	$48.72 - $65.43 $1.8 Million - $2.42 Million	36,940 Added 6.65%	592,423 $32.7 Million
Q3 2023 Nov 14, 2023	BUY	$50.28 - $64.61 $3.47 Million - $4.46 Million	69,077 Added 14.2%	555,483 $32.3 Million
Q2 2023 Aug 14, 2023	BUY	$37.29 - $53.83 $978,265 - $1.41 Million	26,234 Added 5.7%	486,406 $26.2 Million
Q1 2023 May 15, 2023	BUY	$37.61 - $45.72 $458,277 - $557,098	12,185 Added 2.72%	460,172 $18.3 Million
Q4 2022 Feb 14, 2023	SELL	$31.9 - $41.95 $175,226 - $230,431	-5,493 Reduced 1.21%	447,987 $18 Million
Q3 2022 Nov 15, 2022	SELL	$29.83 - $38.01 $365,238 - $465,394	-12,244 Reduced 2.63%	453,480 $14.6 Million
Q2 2022 Aug 15, 2022	BUY	$23.09 - $33.46 $880,698 - $1.28 Million	38,142 Added 8.92%	465,724 $13.8 Million
Q1 2022 May 16, 2022	SELL	$26.91 - $47.15 $269,046 - $471,405	-9,998 Reduced 2.28%	427,582 $12 Million
Q4 2021 Feb 14, 2022	BUY	$32.97 - $56.85 $875,683 - $1.51 Million	26,560 Added 6.46%	437,580 $20.2 Million
Q3 2021 Nov 15, 2021	BUY	$26.48 - $35.99 $290,882 - $395,350	10,985 Added 2.75%	411,020 $13.5 Million
Q2 2021 Aug 16, 2021	BUY	$31.86 - $38.6 $160,669 - $194,659	5,043 Added 1.28%	400,035 $14 Million
Q1 2021 May 17, 2021	BUY	$28.4 - $36.14 $2.27 Million - $2.89 Million	80,083 Added 25.43%	394,992 $14.3 Million
Q4 2020 Feb 16, 2021	BUY	$23.69 - $31.47 $297,830 - $395,640	12,572 Added 4.16%	314,909 $9.15 Million
Q3 2020 Nov 10, 2020	SELL	$26.38 - $33.1 $77,425 - $97,148	-2,935 Reduced 0.96%	302,337 $8.53 Million
Q2 2020 Aug 14, 2020	SELL	$29.93 - $50.1 $601,024 - $1.01 Million	-20,081 Reduced 6.17%	305,272 $9.87 Million
Q1 2020 May 11, 2020	BUY	$30.35 - $67.14 $9.87 Million - $21.8 Million	325,353 New	325,353 $13.3 Million

Others Institutions Holding ANIP

# of Institutions

243

Shares Held

20M

Call Options Held

19.9K

Put Options Held

12.8K

View Full List

About ANI PHARMACEUTICALS INC

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $1.66B
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

More about ANIP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Ani Pharmaceuticals Inc Transaction History